Nachrichten zur Johnson & Johnson Aktie

J&J Investors Are Fixated on Vaccines Like Everyone Else

J&J Investors Are Fixated on Vaccines Like Everyone Else...…

European shares tumble on J&J vaccine worries, banks slide

European shares fell on Tuesday as Johnson & Johnsons move to pause its COVID-19 clinical trials raised doubts about the…

J&J to contribute up to $5 billion to potential opioid settlement

Johnson & Johnson on Tuesday said it will contribute up to $1 billion more to a potential settlement of lawsuits…

Johnson & Johnson Beats Earnings Estimates But Halts Vaccine Trial

Although Johnson & Johnson (NYSE: JNJ) reported third-quarter earnings and revenue that beat Wall Streets expectations, it also revealed that…

S&P 500, Dow snap four-day winning streak as J&J vaccine worries weigh

The Dow and the S&P 500 indexes fell on Tuesday after a four-day winning streak as a pause in Johnson…

J&J Beat Earnings Forecasts. Why the Stock Is Down.

The pharmaceutical company raised its financial forecasts as it reported its third-quarter results.....…

JohnsonJohnson Outperform

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat Johnson & Johnson nach Quartalszahlen auf "Outperform" mit einem Kursziel…

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Dollar strengthens as vaccine, stimulus optimism dented

The U.S. dollar strengthened on Tuesday as investors turned cautious after a Johnson & Johnson Covid-19 study was paused while…

J&J (JNJ) Beats on Q3 Earnings & Sales, Ups 2020 Guidance

J&J (JNJ) beats third-quarter 2020 estimates for both earnings and sales. It increases its adjusted earnings and sales outlook for…

BioNTech und Pfizer testen Corona-Impfstoff auch an Jugendlichen

Frankfurt (Reuters) - Der US-Pharmakonzern Pfizer will den mit der Mainzer Biotechfirma BioNTech entwickelten Corona-Impfstoff auch an Jugendlichen testen.

Von der…

Wall Street retreats after four-day winning streak as J&J vaccine worries weigh

Wall Streets main indexes fell on Tuesday after a four-day winning streak as a pause in Johnson & Johnsons COVID-19…

J&J Shares Slip as Covid-19 Trial Pause Overshadows Outlook

J&J Shares Slip as Covid-19 Trial Pause Overshadows Outlook...…

Wall Street Aims To Slide At Open

Earnings news might be the focus on Tuesday. Investors are alert as Johnson & Johnson said it has paused COVID-19…

Solid Earnings for JNJ Offset Covid-19 Vaccine Trial Setback

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson: Prognose erhöht - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie des US-Pharmazie- und…

Stocks Mixed on J&J Vaccine Setback and Strong Bank Earnings

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

S&P 500, Dow slip on J&J vaccine worries; Apple, Amazon prop up Nasdaq

The S&P 500 and the Dow opened lower as a pause in Johnson & Johnsons COVID-19 vaccine trials weighed, while…

Thinking about trading options or stock in Inmode, Johnson & Johnson, Bank of America, Ford, or Micron Technology?

NEW YORK , Oct. 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INMD,…

Dow Jones, JP Morgan, Johnson & Johnson, Walt Disney, Apple, Amazon - US-Markt

Für den Dow Jones ging es gestern um 0,9 Prozent aufwärts. Bemerkenswerter war jedoch die Entwicklung der US-Techwerte. Der Nasdaq…

Johnson & Johnson: Das bedeuten die Zahlen für Morphosys

Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson (JNJ) wird nach einem besser als erwartet verlaufenen dritten Quartal optimistischer für das…

Johnson & Johnson (JNJ) Q3 Earnings and Revenues Beat Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 10.55% and 2.68%, respectively, for the quarter ended September 2020.…

S&P, Dow futures ease on J&J vaccine worries; bank, tech stocks shine

Futures tied to the Dow and the S&P 500 dipped on Tuesday as investors waited for more information from Johnson…

Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm

Johnson & Johnson (NYSE:JNJ) is the second major company to have encountered a setback in developing a COVID-19 vaccine candidate.…

Stocks making the biggest moves premarket: Johnson & Johnson, Blackrock, JPMorgan Chase

These are the stocks posting the largest moves before the bell....…

Johnson & Johnson Pauses Covid-19 Vaccine Trial Due to Unexplained Illness

The consumer and pharma conglomerate noted that so-called serious adverse events are not “uncommon in clinical trials” notably those involving…

US-Pharmakonzern Johnson & Johnson wird nach gutem Quartal optimistischer

NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson (JohnsonJohnson) wird nach einem besser als erwartet verlaufenen dritten…

Pharmabranche - Johnson & Johnson wird nach gutem Quartal optimistischer

Der US-Konzern Johnson & Johnson wird nach einem besser als erwartet verlaufenen dritten Quartal optimistischer für das Gesamtjahr....…

J&J raises profit forecast as trial halt weighs

Johnson & Johnson raised its annual profit forecast for the second time this year in quarterly results on Tuesday,…

US-Pharmakonzern Johnson & Johnson wird nach gutem Quartal optimistischer

NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson wird nach einem besser…

Johnson & Johnson steigert Gewinn in 3Q deutlich - Prognose angehoben

Von Matt Grossman NEW YORK (Dow Jones)--Johnson Johnson hat im dritten Quartal Umsatz und Gewinn dank einer erhöhten…

Dow futures slip as earnings season kicks off, J&J pauses coronavirus vaccine trial

U.S. stocks early Tuesday point to a mixed start to trade as investors parse corporate earnings from some of the…

Johnson & Johnson beats 3Q profit views, hikes 2020 forecast

Johnson & Johnson boosted revenue slightly and doubled its third-quarter profit, mainly due to a $4 billion charge for litigation…

Johnson & Johnson CFO on third-quarter earnings results

Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat Wall Streets expectations, led by higher sales in…

Johnson & Johnson CFO Joseph Wolk on Covid-19 study pause

The study of Johnson & Johnson's Covid-19 vaccine has been paused due to an unexplained illness in a study participant.…

JOHNSON & JOHNSON: 8-K Report

8-K...…

FTSE 100 on pause after early rewind; vaccine trial suspension weighs on sentiment

FTSE sheds 25 points Dow Jones and S&P to open lower JP Morgan and Johnson & Johnson beat expectations 12.15pm:…

Apple, Disney, Amazon.com, J&J: What to Watch When the Stock Market Opens Today

Amazon.coms Prime Day sales event and Apples new iPhone will vie with Wall Street banks earnings reports for the spotlight…

J&J Darzalex sales up 44%; FY20 outlook raise tops consensus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson reports Q3 earnings beat, raises full-year guidance

Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat Wall Street's expectations, led by higher sales in…

Johnson & Johnson: Q3 Earnings Insights

Shares of Johnson & Johnson (NYSE:JNJ) decreased 1.2% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share…

Johnson & Johnson hikes full-year profit forecast on pharma strength

Johnson & Johnson hiked its full-year profit forecast for the second time in 2020, as strong demand for its…

Johnson & Johnson sales rise nearly 2% on cancer drug demand

Johnson & Johnson reported a 1.7% rise in third-quarter sales on Tuesday due to higher demand for its cancer…

Johnson & Johnson beats third-quarter earnings expectations, raises guidance

Um den gesamten Artikel unter cnbc.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson EPS beats by $0.22, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Reports 2020 Third-Quarter Results

NEW BRUNSWICK, N.J. , Oct. 13, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today…

Johnson & Johnson beats on earning, raises FY20 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J pauses coronavirus vaccine trials due to unexplained illness

Johnson & Johnson has paused clinical trials of its coronavirus vaccine candidate due to an unexplained illness in a…

S&P, Dow futures slip ahead of bank, J&J earnings

Futures tracking the Dow and S&P 500 dipped on Tuesday as investors looked to the big U.S. banks to kick…

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

The study of Johnson & Johnson's Covid-19 vaccine has been paused due to an unexplained illness in a study participant.…